Search
Search Results
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Cunningham, Courtney, author
Pearson, Steven D., author
Kazi, Dhruv S., author
Coxson, Pamela G., author
Moran, Andrew E., author
Penko, Joanne, author
Guzman, David, author
Bibbins-Domingo, Kirsten, author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, November 24, 2015
- Subject(s):
- Anticholesteremic Agents -- therapeutic use
Azetidines -- therapeutic use
Enzyme Inhibitors -- therapeutic use
Hypercholesterolemia -- therapy
Hyperlipoproteinemia Type II -- prevention & control
Proprotein Convertases -- economics
Serine Endopeptidases -- economics
Cholesterol, LDL
Cost-Benefit Analysis
Decision Support Techniques
Drug Costs
Drug Resistance
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Technology Assessment, Biomedical
Treatment Outcome
Value-Based Purchasing
Humans
New England
United States
- Author(s):
- Ollendorf, Daniel A., author
Ollendorf, Daniel A., author
Tarlochan Sandhu, Alexander, author
Chapman, Rick, author
Heidenreich, Paul A., author
Russo, Elizabeth, author
Shore, Karen K., author
Synnott, Patricia, author
Travers, Karin, author
Weissberg, Jed, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, December 1, 2015
- Subject(s):
- Angiotensin II Type 1 Receptor Blockers -- administration & dosage
Antihypertensive Agents -- administration & dosage
Blood Pressure Monitoring, Ambulatory -- instrumentation
Blood Pressure Monitoring, Ambulatory -- methods
Heart Failure -- diagnosis
Heart Failure -- drug therapy
Neprilysin -- administration & dosage
Tetrazoles -- administration & dosage
Valsartan -- administration & dosage
Angiotensin II Type 1 Receptor Blockers -- economics
Antihypertensive Agents -- economics
Cost-Benefit Analysis
Drug Combinations
Drug Costs
Neprilysin -- antagonists & inhibitors
Neprilysin -- economics
Outcome and Process Assessment (Health Care)
Tetrazoles -- economics
Valsartan -- economics
Humans
United States
- Author(s):
- Waxman, Henry, author
Corr, Bill, author
Martin, Kristi, author
Duong, Sophia, author
- Publication:
- [New York, N.Y.] : Commonwealth Fund, July 2017
- Subject(s):
- Cost Control
Drug Costs
Health Policy
Prescription Drugs -- economics
Drug Industry -- economics
Drugs, Generic -- economics
Economic Competition
Legislation, Drug
Orphan Drug Production -- economics
Humans
United States
- Author(s):
- Pearson, Steven D., author
Dreitlein, Bill, author
Henshall, Chris, author
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, March 2016
- Subject(s):
- Drug Costs
Economics, Pharmaceutical
Insurance, Pharmaceutical Services -- economics
Prospective Payment System
Reimbursement Mechanisms -- economics
Cost Savings
Cost Sharing
Formularies
Medicaid -- economics
Medicare -- economics
Off-Label Use -- economics
Pilot Projects
Value-Based Purchasing
Humans
United States
- Author(s):
- Englehardt, Gary V., author
Gruber, Jonathan, author
- Publication:
- Chestnut Hill, MA : Center for Retirement Research at Boston College, June 2011
- Subject(s):
- Financing, Personal
Health Services for the Aged -- economics
Insurance Coverage -- economics
Medicare Part D -- economics
Risk Sharing, Financial
Aged
Drug Costs
Forecasting
Health Care Surveys
Health Expenditures -- statistics & numerical data
Insurance Coverage -- statistics & numerical data
Medicare Part D -- statistics & numerical data
Medicare Part D -- trends
Prescription Drugs -- economics
Socioeconomic Factors
Humans
United States
- Publication:
- [New York, N.Y.] : Commonwealth Fund, [2006]
- Subject(s):
- Health Care Surveys
Insurance, Pharmaceutical Services -- statistics & numerical data
Medicare -- statistics & numerical data
Drug Costs
Insurance Benefits
Public Opinion
United States
- Author(s):
- Cubanski, Juliette, author
Neuman, Tricia, author
Orgera, Kendal, author
Damico, Anthony, author
- Publication:
- Menlo Park, CA : Henry J. Kaiser Family Foundation, November 2017
- Subject(s):
- Drug Costs
Financing, Personal
Health Expenditures
Medicare Part D -- economics
Medicare Part D -- trends
Chronic Disease -- drug therapy
Chronic Disease -- economics
Demography
Hepatitis C -- drug therapy
Leukemia -- drug therapy
Lymphoma -- drug therapy
Poverty
Humans
United States
- Author(s):
- Doshi, Jalpa A., author
Li, Pengxiang, author
Huo, Hairong, author
Pettit, Amy R., author
Armstrong, Katrina A., author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
- Subject(s):
- Antineoplastic Agents -- economics
Antineoplastic Agents -- therapeutic use
Drug Costs
Financing, Personal -- statistics & numerical data
Medication Adherence -- statistics & numerical data
Administration, Oral
Antineoplastic Agents -- administration & dosage
Health Services Accessibility
Prescription Drugs -- economics
Socioeconomic Factors
Time Factors
Humans
United States
- Publication:
- Washington, D.C. : AARP, [2009]
- Subject(s):
- Cost Sharing
Deductibles and Coinsurance
Drug Costs
Formularies as Topic
Aged
Insurance, Pharmaceutical Services -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Humans
United States
- Author(s):
- Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, March 2017
- Subject(s):
- Drug Costs
Insurance Coverage
Medicare Part D -- economics
Cost Savings
Deductibles and Coinsurance
Financing, Personal
Medicare -- legislation & jurisprudence
Humans
United States
United States.
